Global Companion Diagnostics Market Research Report 2024, Forecast to 2032
Report Overview
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.
The global Companion Diagnostics market size was estimated at USD 3971.90 million in 2023 and is projected to reach USD 12123.17 million by 2032, exhibiting a CAGR of 13.20% during the forecast period.
North America Companion Diagnostics market size was estimated at USD 1282.41 million in 2023, at a CAGR of 11.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics market in any manner.
Global Companion Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.
The global Companion Diagnostics market size was estimated at USD 3971.90 million in 2023 and is projected to reach USD 12123.17 million by 2032, exhibiting a CAGR of 13.20% during the forecast period.
North America Companion Diagnostics market size was estimated at USD 1282.41 million in 2023, at a CAGR of 11.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics market in any manner.
Global Companion Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Companion Diagnostics Market
- Overview of the regional outlook of the Companion Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics Market Competitive Situation and Trends
3.6.1 Companion Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS MARKET CONSUMPTION BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 COMPANION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics by Region (2019-2024)
9.2 Global Companion Diagnostics Revenue Market Share by Region (2019-2024)
9.3 Global Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Companion Diagnostics Production
9.4.1 North America Companion Diagnostics Production Growth Rate (2019-2024)
9.4.2 North America Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Companion Diagnostics Production
9.5.1 Europe Companion Diagnostics Production Growth Rate (2019-2024)
9.5.2 Europe Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Companion Diagnostics Production (2019-2024)
9.6.1 Japan Companion Diagnostics Production Growth Rate (2019-2024)
9.6.2 Japan Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Companion Diagnostics Production (2019-2024)
9.7.1 China Companion Diagnostics Production Growth Rate (2019-2024)
9.7.2 China Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Companion Diagnostics Basic Information
10.1.2 Roche Holdings Companion Diagnostics Product Overview
10.1.3 Roche Holdings Companion Diagnostics Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings Companion Diagnostics SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Companion Diagnostics Basic Information
10.2.2 Abbott Laboratories Companion Diagnostics Product Overview
10.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories Companion Diagnostics SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Companion Diagnostics Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
10.3.4 Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
10.3.5 Thermo Fisher Scientific Business Overview
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Companion Diagnostics Basic Information
10.4.2 Agilent Technologies Companion Diagnostics Product Overview
10.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Life Technologies
10.5.1 Life Technologies Companion Diagnostics Basic Information
10.5.2 Life Technologies Companion Diagnostics Product Overview
10.5.3 Life Technologies Companion Diagnostics Product Market Performance
10.5.4 Life Technologies Business Overview
10.5.5 Life Technologies Recent Developments
10.6 GE Healthcare
10.6.1 GE Healthcare Companion Diagnostics Basic Information
10.6.2 GE Healthcare Companion Diagnostics Product Overview
10.6.3 GE Healthcare Companion Diagnostics Product Market Performance
10.6.4 GE Healthcare Business Overview
10.6.5 GE Healthcare Recent Developments
10.7 Agendia
10.7.1 Agendia Companion Diagnostics Basic Information
10.7.2 Agendia Companion Diagnostics Product Overview
10.7.3 Agendia Companion Diagnostics Product Market Performance
10.7.4 Agendia Business Overview
10.7.5 Agendia Recent Developments
10.8 Qiagen
10.8.1 Qiagen Companion Diagnostics Basic Information
10.8.2 Qiagen Companion Diagnostics Product Overview
10.8.3 Qiagen Companion Diagnostics Product Market Performance
10.8.4 Qiagen Business Overview
10.8.5 Qiagen Recent Developments
10.9 Genomic Health
10.9.1 Genomic Health Companion Diagnostics Basic Information
10.9.2 Genomic Health Companion Diagnostics Product Overview
10.9.3 Genomic Health Companion Diagnostics Product Market Performance
10.9.4 Genomic Health Business Overview
10.9.5 Genomic Health Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Companion Diagnostics Basic Information
10.10.2 Myriad Genetics Companion Diagnostics Product Overview
10.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Companion Diagnostics Basic Information
10.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
10.11.4 Advanced Cell Diagnostics Business Overview
10.11.5 Advanced Cell Diagnostics Recent Developments
10.12 Danaher
10.12.1 Danaher Companion Diagnostics Basic Information
10.12.2 Danaher Companion Diagnostics Product Overview
10.12.3 Danaher Companion Diagnostics Product Market Performance
10.12.4 Danaher Business Overview
10.12.5 Danaher Recent Developments
10.13 Applied Proteomics
10.13.1 Applied Proteomics Companion Diagnostics Basic Information
10.13.2 Applied Proteomics Companion Diagnostics Product Overview
10.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
10.13.4 Applied Proteomics Business Overview
10.13.5 Applied Proteomics Recent Developments
11 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics Market Size Forecast
11.2 Global Companion Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
11.2.4 South America Companion Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Companion Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2025-2032)
12.1.2 Global Companion Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Companion Diagnostics by Type (2025-2032)
12.2 Global Companion Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostics Sales Sites, Area Served, Product Type
3.6 Companion Diagnostics Market Competitive Situation and Trends
3.6.1 Companion Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostics Price by Type (2019-2024)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTICS MARKET CONSUMPTION BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 COMPANION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics by Region (2019-2024)
9.2 Global Companion Diagnostics Revenue Market Share by Region (2019-2024)
9.3 Global Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Companion Diagnostics Production
9.4.1 North America Companion Diagnostics Production Growth Rate (2019-2024)
9.4.2 North America Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Companion Diagnostics Production
9.5.1 Europe Companion Diagnostics Production Growth Rate (2019-2024)
9.5.2 Europe Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Companion Diagnostics Production (2019-2024)
9.6.1 Japan Companion Diagnostics Production Growth Rate (2019-2024)
9.6.2 Japan Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Companion Diagnostics Production (2019-2024)
9.7.1 China Companion Diagnostics Production Growth Rate (2019-2024)
9.7.2 China Companion Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Companion Diagnostics Basic Information
10.1.2 Roche Holdings Companion Diagnostics Product Overview
10.1.3 Roche Holdings Companion Diagnostics Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings Companion Diagnostics SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Companion Diagnostics Basic Information
10.2.2 Abbott Laboratories Companion Diagnostics Product Overview
10.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories Companion Diagnostics SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Companion Diagnostics Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
10.3.4 Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
10.3.5 Thermo Fisher Scientific Business Overview
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Companion Diagnostics Basic Information
10.4.2 Agilent Technologies Companion Diagnostics Product Overview
10.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Life Technologies
10.5.1 Life Technologies Companion Diagnostics Basic Information
10.5.2 Life Technologies Companion Diagnostics Product Overview
10.5.3 Life Technologies Companion Diagnostics Product Market Performance
10.5.4 Life Technologies Business Overview
10.5.5 Life Technologies Recent Developments
10.6 GE Healthcare
10.6.1 GE Healthcare Companion Diagnostics Basic Information
10.6.2 GE Healthcare Companion Diagnostics Product Overview
10.6.3 GE Healthcare Companion Diagnostics Product Market Performance
10.6.4 GE Healthcare Business Overview
10.6.5 GE Healthcare Recent Developments
10.7 Agendia
10.7.1 Agendia Companion Diagnostics Basic Information
10.7.2 Agendia Companion Diagnostics Product Overview
10.7.3 Agendia Companion Diagnostics Product Market Performance
10.7.4 Agendia Business Overview
10.7.5 Agendia Recent Developments
10.8 Qiagen
10.8.1 Qiagen Companion Diagnostics Basic Information
10.8.2 Qiagen Companion Diagnostics Product Overview
10.8.3 Qiagen Companion Diagnostics Product Market Performance
10.8.4 Qiagen Business Overview
10.8.5 Qiagen Recent Developments
10.9 Genomic Health
10.9.1 Genomic Health Companion Diagnostics Basic Information
10.9.2 Genomic Health Companion Diagnostics Product Overview
10.9.3 Genomic Health Companion Diagnostics Product Market Performance
10.9.4 Genomic Health Business Overview
10.9.5 Genomic Health Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Companion Diagnostics Basic Information
10.10.2 Myriad Genetics Companion Diagnostics Product Overview
10.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Companion Diagnostics Basic Information
10.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
10.11.4 Advanced Cell Diagnostics Business Overview
10.11.5 Advanced Cell Diagnostics Recent Developments
10.12 Danaher
10.12.1 Danaher Companion Diagnostics Basic Information
10.12.2 Danaher Companion Diagnostics Product Overview
10.12.3 Danaher Companion Diagnostics Product Market Performance
10.12.4 Danaher Business Overview
10.12.5 Danaher Recent Developments
10.13 Applied Proteomics
10.13.1 Applied Proteomics Companion Diagnostics Basic Information
10.13.2 Applied Proteomics Companion Diagnostics Product Overview
10.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
10.13.4 Applied Proteomics Business Overview
10.13.5 Applied Proteomics Recent Developments
11 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics Market Size Forecast
11.2 Global Companion Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
11.2.4 South America Companion Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Companion Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2025-2032)
12.1.2 Global Companion Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Companion Diagnostics by Type (2025-2032)
12.2 Global Companion Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Table 10. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics Product Type
Table 13. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Global Companion Diagnostics Sales by Type (K Units)
Table 23. Global Companion Diagnostics Market Size by Type (M USD)
Table 24. Global Companion Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics Sales (K Units) by Application
Table 30. Global Companion Diagnostics Market Size by Application
Table 31. Global Companion Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Global Companion Diagnostics Production (K Units) by Region (2019-2024)
Table 44. Global Companion Diagnostics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Companion Diagnostics Revenue Market Share by Region (2019-2024)
Table 46. Global Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Holdings Companion Diagnostics Basic Information
Table 52. Roche Holdings Companion Diagnostics Product Overview
Table 53. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Holdings Business Overview
Table 55. Roche Holdings Companion Diagnostics SWOT Analysis
Table 56. Roche Holdings Recent Developments
Table 57. Abbott Laboratories Companion Diagnostics Basic Information
Table 58. Abbott Laboratories Companion Diagnostics Product Overview
Table 59. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Companion Diagnostics SWOT Analysis
Table 62. Abbott Laboratories Recent Developments
Table 63. Thermo Fisher Scientific Companion Diagnostics Basic Information
Table 64. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 65. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Agilent Technologies Companion Diagnostics Basic Information
Table 70. Agilent Technologies Companion Diagnostics Product Overview
Table 71. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Recent Developments
Table 74. Life Technologies Companion Diagnostics Basic Information
Table 75. Life Technologies Companion Diagnostics Product Overview
Table 76. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Life Technologies Business Overview
Table 78. Life Technologies Recent Developments
Table 79. GE Healthcare Companion Diagnostics Basic Information
Table 80. GE Healthcare Companion Diagnostics Product Overview
Table 81. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Recent Developments
Table 84. Agendia Companion Diagnostics Basic Information
Table 85. Agendia Companion Diagnostics Product Overview
Table 86. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Agendia Business Overview
Table 88. Agendia Recent Developments
Table 89. Qiagen Companion Diagnostics Basic Information
Table 90. Qiagen Companion Diagnostics Product Overview
Table 91. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Qiagen Business Overview
Table 93. Qiagen Recent Developments
Table 94. Genomic Health Companion Diagnostics Basic Information
Table 95. Genomic Health Companion Diagnostics Product Overview
Table 96. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Genomic Health Business Overview
Table 98. Genomic Health Recent Developments
Table 99. Myriad Genetics Companion Diagnostics Basic Information
Table 100. Myriad Genetics Companion Diagnostics Product Overview
Table 101. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. Advanced Cell Diagnostics Companion Diagnostics Basic Information
Table 105. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 106. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Advanced Cell Diagnostics Business Overview
Table 108. Advanced Cell Diagnostics Recent Developments
Table 109. Danaher Companion Diagnostics Basic Information
Table 110. Danaher Companion Diagnostics Product Overview
Table 111. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Danaher Business Overview
Table 113. Danaher Recent Developments
Table 114. Applied Proteomics Companion Diagnostics Basic Information
Table 115. Applied Proteomics Companion Diagnostics Product Overview
Table 116. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Applied Proteomics Business Overview
Table 118. Applied Proteomics Recent Developments
Table 119. Global Companion Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Companion Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Companion Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Companion Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Companion Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Companion Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Companion Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Companion Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Companion Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)
Table 10. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostics Product Type
Table 13. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Global Companion Diagnostics Sales by Type (K Units)
Table 23. Global Companion Diagnostics Market Size by Type (M USD)
Table 24. Global Companion Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostics Sales (K Units) by Application
Table 30. Global Companion Diagnostics Market Size by Application
Table 31. Global Companion Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostics Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Global Companion Diagnostics Production (K Units) by Region (2019-2024)
Table 44. Global Companion Diagnostics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Companion Diagnostics Revenue Market Share by Region (2019-2024)
Table 46. Global Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Holdings Companion Diagnostics Basic Information
Table 52. Roche Holdings Companion Diagnostics Product Overview
Table 53. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Holdings Business Overview
Table 55. Roche Holdings Companion Diagnostics SWOT Analysis
Table 56. Roche Holdings Recent Developments
Table 57. Abbott Laboratories Companion Diagnostics Basic Information
Table 58. Abbott Laboratories Companion Diagnostics Product Overview
Table 59. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Companion Diagnostics SWOT Analysis
Table 62. Abbott Laboratories Recent Developments
Table 63. Thermo Fisher Scientific Companion Diagnostics Basic Information
Table 64. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 65. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Thermo Fisher Scientific Companion Diagnostics SWOT Analysis
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Agilent Technologies Companion Diagnostics Basic Information
Table 70. Agilent Technologies Companion Diagnostics Product Overview
Table 71. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Recent Developments
Table 74. Life Technologies Companion Diagnostics Basic Information
Table 75. Life Technologies Companion Diagnostics Product Overview
Table 76. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Life Technologies Business Overview
Table 78. Life Technologies Recent Developments
Table 79. GE Healthcare Companion Diagnostics Basic Information
Table 80. GE Healthcare Companion Diagnostics Product Overview
Table 81. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Recent Developments
Table 84. Agendia Companion Diagnostics Basic Information
Table 85. Agendia Companion Diagnostics Product Overview
Table 86. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Agendia Business Overview
Table 88. Agendia Recent Developments
Table 89. Qiagen Companion Diagnostics Basic Information
Table 90. Qiagen Companion Diagnostics Product Overview
Table 91. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Qiagen Business Overview
Table 93. Qiagen Recent Developments
Table 94. Genomic Health Companion Diagnostics Basic Information
Table 95. Genomic Health Companion Diagnostics Product Overview
Table 96. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Genomic Health Business Overview
Table 98. Genomic Health Recent Developments
Table 99. Myriad Genetics Companion Diagnostics Basic Information
Table 100. Myriad Genetics Companion Diagnostics Product Overview
Table 101. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. Advanced Cell Diagnostics Companion Diagnostics Basic Information
Table 105. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 106. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Advanced Cell Diagnostics Business Overview
Table 108. Advanced Cell Diagnostics Recent Developments
Table 109. Danaher Companion Diagnostics Basic Information
Table 110. Danaher Companion Diagnostics Product Overview
Table 111. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Danaher Business Overview
Table 113. Danaher Recent Developments
Table 114. Applied Proteomics Companion Diagnostics Basic Information
Table 115. Applied Proteomics Companion Diagnostics Product Overview
Table 116. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Applied Proteomics Business Overview
Table 118. Applied Proteomics Recent Developments
Table 119. Global Companion Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Companion Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Companion Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Companion Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Companion Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Companion Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Companion Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Companion Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Companion Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Companion Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Companion Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Companion Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics Market Share by Application
Figure 24. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics Market Share by Application in 2023
Figure 28. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics Production Market Share by Region (2019-2024)
Figure 62. North America Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 65. China Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Companion Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Companion Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Companion Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Companion Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Companion Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Companion Diagnostics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Companion Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Companion Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostics Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostics by Type in 2023
Figure 20. Market Size Share of Companion Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostics Market Share by Application
Figure 24. Global Companion Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostics Market Share by Application in 2023
Figure 28. Global Companion Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostics Production Market Share by Region (2019-2024)
Figure 62. North America Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 65. China Companion Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Companion Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Companion Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Companion Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Companion Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Companion Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Companion Diagnostics Market Share Forecast by Application (2025-2032)
